NEXTGEN HEALTHCARE, INC.

2023 Q4 Form 10-Q Financial Statement

#000095017023054878 Filed on October 24, 2023

View on sec.gov

Income Statement

Concept 2023 Q4 2023 Q3

Balance Sheet

Concept 2023 Q4 2023 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $200.3M
YoY Change 183.2%
Cash & Equivalents $53.87M
Short-Term Investments $146.4M
Other Short-Term Assets $1.732M
YoY Change 1.17%
Inventory
Prepaid Expenses $22.67M
Receivables $89.28M
Other Receivables $8.134M
Total Short-Term Assets $362.8M
YoY Change 66.31%
LONG-TERM ASSETS
Property, Plant & Equipment $4.939M
YoY Change -33.24%
Goodwill $322.0M
YoY Change 20.5%
Intangibles $24.48M
YoY Change 24.02%
Long-Term Investments
YoY Change
Other Assets $46.22M
YoY Change 18.71%
Total Long-Term Assets $495.0M
YoY Change 21.02%
TOTAL ASSETS
Total Short-Term Assets $362.8M
Total Long-Term Assets $495.0M
Total Assets $857.8M
YoY Change 36.77%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $10.47M
YoY Change -15.68%
Accrued Expenses $66.91M
YoY Change -0.29%
Deferred Revenue $45.93M
YoY Change -26.51%
Short-Term Debt $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $143.9M
YoY Change -14.67%
LONG-TERM LIABILITIES
Long-Term Debt $267.6M
YoY Change
Other Long-Term Liabilities $9.037M
YoY Change 98.35%
Total Long-Term Liabilities $9.037M
YoY Change 98.35%
TOTAL LIABILITIES
Total Short-Term Liabilities $143.9M
Total Long-Term Liabilities $9.037M
Total Liabilities $434.5M
YoY Change 134.48%
SHAREHOLDERS EQUITY
Retained Earnings $138.8M
YoY Change -4.28%
Common Stock $371.8M
YoY Change 7.92%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $423.3M
YoY Change
Total Liabilities & Shareholders Equity $857.8M
YoY Change 36.77%

Cashflow Statement

Concept 2023 Q4 2023 Q3

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Amendment Flag
AmendmentFlag
false
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2
dei Entity Central Index Key
EntityCentralIndexKey
0000708818
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2024
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--03-31
CY2023Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2023Q1 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2023-09-30
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
001-12537
dei Entity Registrant Name
EntityRegistrantName
NEXTGEN HEALTHCARE, INC.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
95-2888568
dei Security12b Title
Security12bTitle
Common Stock, $0.01 Par Value
dei Trading Symbol
TradingSymbol
NXGN
dei Security Exchange Name
SecurityExchangeName
NASDAQ
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
dei Entity Small Business
EntitySmallBusiness
false
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
CY2023Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
67096894
CY2023Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
53867000
CY2023Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
98719000
CY2023Q3 us-gaap Restricted Cash And Cash Equivalents At Carrying Value
RestrictedCashAndCashEquivalentsAtCarryingValue
4914000
CY2023Q1 us-gaap Restricted Cash And Cash Equivalents At Carrying Value
RestrictedCashAndCashEquivalentsAtCarryingValue
7269000
CY2023Q3 us-gaap Marketable Securities
MarketableSecurities
146432000
CY2023Q1 us-gaap Marketable Securities
MarketableSecurities
139612000
CY2023Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
89277000
CY2023Q1 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
88498000
CY2023Q3 us-gaap Contract With Customer Asset Net Current
ContractWithCustomerAssetNetCurrent
20489000
CY2023Q1 us-gaap Contract With Customer Asset Net Current
ContractWithCustomerAssetNetCurrent
19561000
CY2023Q3 us-gaap Income Taxes Receivable
IncomeTaxesReceivable
8134000
CY2023Q1 us-gaap Income Taxes Receivable
IncomeTaxesReceivable
5248000
CY2023Q3 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
39684000
CY2023Q1 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
42916000
CY2023Q3 us-gaap Assets Current
AssetsCurrent
362797000
CY2023Q1 us-gaap Assets Current
AssetsCurrent
401823000
CY2023Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
4939000
CY2023Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
6421000
CY2023Q3 us-gaap Capitalized Computer Software Net
CapitalizedComputerSoftwareNet
59875000
CY2023Q1 us-gaap Capitalized Computer Software Net
CapitalizedComputerSoftwareNet
54516000
CY2023Q3 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
2615000
CY2023Q1 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
3335000
CY2023Q3 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
29210000
CY2023Q1 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
29472000
CY2023Q3 us-gaap Contract With Customer Asset Net Noncurrent
ContractWithCustomerAssetNetNoncurrent
5616000
CY2023Q1 us-gaap Contract With Customer Asset Net Noncurrent
ContractWithCustomerAssetNetNoncurrent
5572000
CY2023Q3 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
24480000
CY2023Q1 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
28968000
CY2023Q3 us-gaap Goodwill
Goodwill
322001000
CY2023Q1 us-gaap Goodwill
Goodwill
321756000
CY2023Q3 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
46217000
CY2023Q1 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
44238000
CY2023Q3 us-gaap Assets
Assets
857750000
CY2023Q1 us-gaap Assets
Assets
896101000
CY2023Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
10467000
CY2023Q1 us-gaap Accounts Payable Current
AccountsPayableCurrent
12022000
CY2023Q3 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
45932000
CY2023Q1 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
61601000
CY2023Q3 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
28407000
CY2023Q1 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
36241000
CY2023Q3 us-gaap Taxes Payable Current
TaxesPayableCurrent
604000
CY2023Q1 us-gaap Taxes Payable Current
TaxesPayableCurrent
622000
CY2023Q3 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
3471000
CY2023Q1 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
3826000
CY2023Q3 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
54997000
CY2023Q1 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
83799000
CY2023Q3 us-gaap Liabilities Current
LiabilitiesCurrent
143878000
CY2023Q1 us-gaap Liabilities Current
LiabilitiesCurrent
198111000
CY2023Q3 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
2809000
CY2023Q1 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
10310000
CY2023Q3 us-gaap Deferred Compensation Liability Classified Noncurrent
DeferredCompensationLiabilityClassifiedNoncurrent
8722000
CY2023Q1 us-gaap Deferred Compensation Liability Classified Noncurrent
DeferredCompensationLiabilityClassifiedNoncurrent
8033000
CY2023Q3 us-gaap Convertible Debt Noncurrent
ConvertibleDebtNoncurrent
267565000
CY2023Q1 us-gaap Convertible Debt Noncurrent
ConvertibleDebtNoncurrent
266843000
CY2023Q3 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
2464000
CY2023Q1 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
4095000
CY2023Q3 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
9037000
CY2023Q1 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
8274000
CY2023Q3 us-gaap Liabilities
Liabilities
434475000
CY2023Q1 us-gaap Liabilities
Liabilities
495666000
CY2023Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2023Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2023Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000
CY2023Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000
CY2023Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
71946000
CY2023Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
70875000
CY2023Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
67097000
CY2023Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
66026000
CY2023Q3 us-gaap Common Stock Value
CommonStockValue
719000
CY2023Q1 us-gaap Common Stock Value
CommonStockValue
709000
CY2023Q3 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
4849000
CY2023Q1 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
4849000
CY2023Q3 us-gaap Treasury Stock Common Value
TreasuryStockCommonValue
85752000
CY2023Q1 us-gaap Treasury Stock Common Value
TreasuryStockCommonValue
85752000
CY2023Q3 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
371080000
CY2023Q1 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
359342000
CY2023Q3 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-1581000
CY2023Q1 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-1462000
CY2023Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
138809000
CY2023Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
127598000
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
423275000
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
400435000
CY2023Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
857750000
CY2023Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
896101000
CY2023Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
176418000
CY2022Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
159443000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
354625000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
312745000
CY2023Q3 nxgn Cost Of Goods And Services Sold Amortization Of Capitalized Software Costs And Acquired Intangible Assets
CostOfGoodsAndServicesSoldAmortizationOfCapitalizedSoftwareCostsAndAcquiredIntangibleAssets
7181000
CY2022Q3 nxgn Cost Of Goods And Services Sold Amortization Of Capitalized Software Costs And Acquired Intangible Assets
CostOfGoodsAndServicesSoldAmortizationOfCapitalizedSoftwareCostsAndAcquiredIntangibleAssets
6744000
nxgn Cost Of Goods And Services Sold Amortization Of Capitalized Software Costs And Acquired Intangible Assets
CostOfGoodsAndServicesSoldAmortizationOfCapitalizedSoftwareCostsAndAcquiredIntangibleAssets
14172000
nxgn Cost Of Goods And Services Sold Amortization Of Capitalized Software Costs And Acquired Intangible Assets
CostOfGoodsAndServicesSoldAmortizationOfCapitalizedSoftwareCostsAndAcquiredIntangibleAssets
13878000
CY2023Q3 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
94797000
CY2022Q3 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
82580000
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
193183000
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
162634000
CY2023Q3 us-gaap Gross Profit
GrossProfit
81621000
CY2022Q3 us-gaap Gross Profit
GrossProfit
76863000
us-gaap Gross Profit
GrossProfit
161442000
us-gaap Gross Profit
GrossProfit
150111000
CY2023Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
54175000
CY2022Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
44886000
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
102368000
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
93920000
CY2023Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
18020000
CY2022Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
20857000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
38945000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
42652000
CY2023Q3 nxgn Amortization Of Intangible Assets Acquired
AmortizationOfIntangibleAssetsAcquired
1189000
CY2022Q3 nxgn Amortization Of Intangible Assets Acquired
AmortizationOfIntangibleAssetsAcquired
705000
nxgn Amortization Of Intangible Assets Acquired
AmortizationOfIntangibleAssetsAcquired
2377000
nxgn Amortization Of Intangible Assets Acquired
AmortizationOfIntangibleAssetsAcquired
1410000
CY2023Q3 us-gaap Asset Impairment Charges
AssetImpairmentCharges
166000
CY2022Q3 us-gaap Asset Impairment Charges
AssetImpairmentCharges
805000
us-gaap Asset Impairment Charges
AssetImpairmentCharges
525000
us-gaap Asset Impairment Charges
AssetImpairmentCharges
1329000
CY2023Q3 us-gaap Restructuring Charges
RestructuringCharges
15000
CY2022Q3 us-gaap Restructuring Charges
RestructuringCharges
321000
us-gaap Restructuring Charges
RestructuringCharges
105000
us-gaap Restructuring Charges
RestructuringCharges
321000
CY2023Q3 us-gaap Operating Expenses
OperatingExpenses
73565000
CY2022Q3 us-gaap Operating Expenses
OperatingExpenses
67574000
us-gaap Operating Expenses
OperatingExpenses
144320000
us-gaap Operating Expenses
OperatingExpenses
139632000
CY2023Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
8056000
CY2022Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
9289000
us-gaap Operating Income Loss
OperatingIncomeLoss
17122000
us-gaap Operating Income Loss
OperatingIncomeLoss
10479000
CY2023Q3 us-gaap Investment Income Interest
InvestmentIncomeInterest
1520000
CY2022Q3 us-gaap Investment Income Interest
InvestmentIncomeInterest
74000
us-gaap Investment Income Interest
InvestmentIncomeInterest
3189000
us-gaap Investment Income Interest
InvestmentIncomeInterest
120000
CY2023Q3 us-gaap Interest Expense
InterestExpense
3310000
CY2022Q3 us-gaap Interest Expense
InterestExpense
325000
us-gaap Interest Expense
InterestExpense
6549000
us-gaap Interest Expense
InterestExpense
655000
CY2023Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
430000
CY2022Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
10292000
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
1480000
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
10287000
CY2023Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
6696000
CY2022Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
19330000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
15242000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
20231000
CY2023Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
1641000
CY2022Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
5707000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
4031000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
5460000
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
5055000
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
13623000
us-gaap Net Income Loss
NetIncomeLoss
11211000
us-gaap Net Income Loss
NetIncomeLoss
14771000
CY2023Q3 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-76000
CY2022Q3 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-5000
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-77000
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-33000
CY2023Q3 us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
734000
us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
-42000
CY2023Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
5713000
CY2022Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
13618000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
11092000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
14738000
CY2023Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.08
CY2022Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.2
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.17
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.22
CY2023Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.07
CY2022Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.2
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.17
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.22
CY2023Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
67074000
CY2022Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
67806000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
66749000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
67698000
CY2023Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
67690000
CY2022Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
68422000
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
67280000
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
68353000
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
400435000
CY2023Q2 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
-3248000
CY2023Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
7956000
CY2023Q2 us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
-776000
CY2023Q2 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-1000
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
6156000
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
410522000
CY2023Q3 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
-2426000
CY2023Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
9466000
CY2023Q3 us-gaap Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Net Of Tax
OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax
734000
CY2023Q3 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-76000
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
5055000
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
423275000
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
423078000
CY2022Q2 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
-1600000
CY2022Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
8766000
CY2022Q2 us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
2505000
CY2022Q2 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-28000
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
1148000
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
428859000
CY2022Q3 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
-1949000
CY2022Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
8687000
CY2022Q3 us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
7373000
CY2022Q3 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-5000
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
13623000
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
441842000
CY2022Q2 us-gaap Treasury Stock Acquired Average Cost Per Share
TreasuryStockAcquiredAverageCostPerShare
16.93
CY2022Q3 us-gaap Treasury Stock Acquired Average Cost Per Share
TreasuryStockAcquiredAverageCostPerShare
17.21
us-gaap Net Income Loss
NetIncomeLoss
11211000
us-gaap Net Income Loss
NetIncomeLoss
14771000
us-gaap Capitalized Computer Software Amortization1
CapitalizedComputerSoftwareAmortization1
12061000
us-gaap Capitalized Computer Software Amortization1
CapitalizedComputerSoftwareAmortization1
10725000
us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
976000
us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
254000
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
4488000
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
4564000
us-gaap Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
1956000
us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
400000
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
1430000
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
2575000
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
9878000
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
7104000
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
6124000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-5674000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-13427000
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
-130000
us-gaap Depreciation
Depreciation
2064000
us-gaap Depreciation
Depreciation
2646000
nxgn Excess Tax Deficiency Benefit From Share Based Compensation Operating Activities
ExcessTaxDeficiencyBenefitFromShareBasedCompensationOperatingActivities
170000
nxgn Excess Tax Deficiency Benefit From Share Based Compensation Operating Activities
ExcessTaxDeficiencyBenefitFromShareBasedCompensationOperatingActivities
-434000
nxgn Gain Loss On Disposition Of Commercial Dental Assets
GainLossOnDispositionOfCommercialDentalAssets
10296000
nxgn Noncash Asset Impairment Charges
NoncashAssetImpairmentCharges
171000
nxgn Noncash Asset Impairment Charges
NoncashAssetImpairmentCharges
1329000
us-gaap Marketable Securities Realized Gain Loss Excluding Other Than Temporary Impairments
MarketableSecuritiesRealizedGainLossExcludingOtherThanTemporaryImpairments
-734000
us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
-37000
us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
-74000
us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-100000
us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-7000
us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
763000
us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
1682000
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
1826000
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
600000
us-gaap Share Based Compensation
ShareBasedCompensation
17422000
us-gaap Share Based Compensation
ShareBasedCompensation
17453000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
2606000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
1527000
us-gaap Increase Decrease In Contract With Customer Asset
IncreaseDecreaseInContractWithCustomerAsset
972000
us-gaap Increase Decrease In Contract With Customer Asset
IncreaseDecreaseInContractWithCustomerAsset
2000
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-1571000
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
3153000
us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
-23170000
us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
1739000
us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
-7802000
us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
-20422000
us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
-2825000
us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
3934000
us-gaap Increase Decrease In Deferred Compensation
IncreaseDecreaseInDeferredCompensation
689000
us-gaap Increase Decrease In Deferred Compensation
IncreaseDecreaseInDeferredCompensation
-249000
nxgn Increase Decrease In Operating Lease Liabilities
IncreaseDecreaseInOperatingLeaseLiabilities
1979000
nxgn Increase Decrease In Operating Lease Liabilities
IncreaseDecreaseInOperatingLeaseLiabilities
4097000
us-gaap Increase Decrease In Other Operating Capital Net
IncreaseDecreaseInOtherOperatingCapitalNet
27746000
us-gaap Increase Decrease In Other Operating Capital Net
IncreaseDecreaseInOtherOperatingCapitalNet
-7892000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-17515000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
33796000
us-gaap Payments To Acquire Software
PaymentsToAcquireSoftware
17420000
us-gaap Payments To Acquire Software
PaymentsToAcquireSoftware
18416000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
854000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
1426000
us-gaap Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
15457000
nxgn Proceeds From Maturities And Redemptions Of Marketable Securities
ProceedsFromMaturitiesAndRedemptionsOfMarketableSecurities
42871000
us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
63942000
nxgn Proceeds From Disposition Of Commercial Dental Assets
ProceedsFromDispositionOfCommercialDentalAssets
11253000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-23888000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-8589000
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
-219000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-47207000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
11561000
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
105988000
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
66747000
CY2023Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
58781000
CY2022Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
78308000
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
6689000
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
1963000
us-gaap Proceeds From Income Tax Refunds
ProceedsFromIncomeTaxRefunds
4000
us-gaap Proceeds From Income Tax Refunds
ProceedsFromIncomeTaxRefunds
9000
us-gaap Interest Paid Net
InterestPaidNet
5723000
us-gaap Interest Paid Net
InterestPaidNet
190000
us-gaap Operating Lease Payments
OperatingLeasePayments
2127000
us-gaap Operating Lease Payments
OperatingLeasePayments
4533000
us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
585000
us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
20000
us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
144000
CY2023Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2023Q3 nxgn Business Combination Consideration Transferred Equity Interests Issued Issuable And Outstanding Per Share
BusinessCombinationConsiderationTransferredEquityInterestsIssuedIssuableAndOutstandingPerShare
23.95
us-gaap Use Of Estimates
UseOfEstimates
<p style="text-indent:0;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:9pt;font-family:Arial;font-style:italic;min-width:fit-content;">Use of Estimates.</span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:9pt;font-family:Arial;min-width:fit-content;"> The consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“GAAP”), which requires us to make estimates and assumptions that affect the amounts reported and disclosed in the consolidated financial statements and the accompanying notes. Actual results could differ materially from these estimates. We evaluate our estimates on an ongoing basis. We base our estimates on historical experience and on various other assumptions that are believed to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities and recording revenue and expenses during the period.</span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:9pt;font-family:Arial;min-width:fit-content;"> </span></p>
CY2023Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
176418000
CY2022Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
159443000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
354625000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
312745000
CY2023Q3 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
726000000
CY2023Q3 us-gaap Revenue Remaining Performance Obligation Percentage
RevenueRemainingPerformanceObligationPercentage
0.06
CY2023Q3 nxgn Percentage Of Revenue Expected To Recognize Over Next Period
PercentageOfRevenueExpectedToRecognizeOverNextPeriod
0.53
CY2022Q3 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
563900000
CY2022Q3 us-gaap Revenue Remaining Performance Obligation Percentage
RevenueRemainingPerformanceObligationPercentage
0.09
CY2022Q3 nxgn Percentage Of Revenue Expected To Recognize Over Next Period
PercentageOfRevenueExpectedToRecognizeOverNextPeriod
0.51
CY2023Q3 nxgn Contract With Customer Liability Balance Or Invoiced To Customers
ContractWithCustomerLiabilityBalanceOrInvoicedToCustomers
18672000
CY2022Q3 nxgn Contract With Customer Liability Balance Or Invoiced To Customers
ContractWithCustomerLiabilityBalanceOrInvoicedToCustomers
17521000
nxgn Contract With Customer Liability Balance Or Invoiced To Customers
ContractWithCustomerLiabilityBalanceOrInvoicedToCustomers
36917000
nxgn Contract With Customer Liability Balance Or Invoiced To Customers
ContractWithCustomerLiabilityBalanceOrInvoicedToCustomers
35245000
nxgn Capitalized Commission Costs
CapitalizedCommissionCosts
41862000
CY2023Q3 nxgn Commission Expense Related To Amortization Of Capitalized Commission Costs
CommissionExpenseRelatedToAmortizationOfCapitalizedCommissionCosts
4356000
CY2022Q3 nxgn Commission Expense Related To Amortization Of Capitalized Commission Costs
CommissionExpenseRelatedToAmortizationOfCapitalizedCommissionCosts
3634000
nxgn Commission Expense Related To Amortization Of Capitalized Commission Costs
CommissionExpenseRelatedToAmortizationOfCapitalizedCommissionCosts
8329000
nxgn Commission Expense Related To Amortization Of Capitalized Commission Costs
CommissionExpenseRelatedToAmortizationOfCapitalizedCommissionCosts
7121000
CY2023Q1 us-gaap Capitalized Computer Software Net
CapitalizedComputerSoftwareNet
54516000
CY2023Q3 us-gaap Capitalized Computer Software Amortization1
CapitalizedComputerSoftwareAmortization1
6125000
CY2022Q3 us-gaap Capitalized Computer Software Amortization1
CapitalizedComputerSoftwareAmortization1
5371000
us-gaap Capitalized Computer Software Amortization1
CapitalizedComputerSoftwareAmortization1
12061000
us-gaap Capitalized Computer Software Amortization1
CapitalizedComputerSoftwareAmortization1
10725000
CY2023Q3 us-gaap Accounts Receivable Gross Current
AccountsReceivableGrossCurrent
93289000
CY2023Q1 us-gaap Accounts Receivable Gross Current
AccountsReceivableGrossCurrent
92360000
CY2023Q3 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
4012000
CY2023Q1 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
3862000
CY2023Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
89277000
CY2023Q1 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
88498000
CY2023Q2 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
3906000
CY2023Q3 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
951000
CY2023Q3 us-gaap Allowance For Doubtful Accounts Receivable Write Offs
AllowanceForDoubtfulAccountsReceivableWriteOffs
845000
CY2023Q3 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
4012000
CY2023Q1 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
3862000
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
1826000
us-gaap Allowance For Doubtful Accounts Receivable Write Offs
AllowanceForDoubtfulAccountsReceivableWriteOffs
1676000
CY2023Q3 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
4012000
CY2023Q1 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value
FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
3800000
us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
400000
CY2023Q3 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value
FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
4200000
CY2023Q3 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
146432000
CY2023Q3 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
146432000
CY2023Q3 nxgn Investments Amortized Cost Basis
InvestmentsAmortizedCostBasis
168699000
CY2023Q3 us-gaap Investments Fair Value Disclosure
InvestmentsFairValueDisclosure
168699000
CY2023Q1 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
139572000
CY2023Q1 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
129000
CY2023Q1 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
89000
CY2023Q1 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
139612000
CY2023Q1 nxgn Investments Amortized Cost Basis
InvestmentsAmortizedCostBasis
170511000
CY2023Q1 nxgn Investments Accumulated Unrealized Gain
InvestmentsAccumulatedUnrealizedGain
131000
CY2023Q1 nxgn Investments Accumulated Unrealized Loss
InvestmentsAccumulatedUnrealizedLoss
89000
CY2023Q1 us-gaap Investments Fair Value Disclosure
InvestmentsFairValueDisclosure
170553000
CY2023Q3 us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
734000
CY2023Q3 us-gaap Available For Sale Securities Debt Maturities Within One Year Amortized Cost
AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost
123457000
CY2023Q3 us-gaap Available For Sale Securities Debt Maturities Within One Year Fair Value
AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue
123457000
CY2023Q3 us-gaap Available For Sale Securities Debt Maturities After One Through Five Years Amortized Cost
AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost
45242000
CY2023Q3 us-gaap Available For Sale Securities Debt Maturities After One Through Five Years Fair Value
AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue
45242000
CY2023Q3 us-gaap Available For Sale Securities Debt Maturities Single Maturity Date Amortized Cost Basis
AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasis
168699000
CY2023Q3 us-gaap Available For Sale Securities Debt Maturities Single Maturity Date
AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDate
168699000
CY2023Q3 us-gaap Lease Cost
LeaseCost
231000
CY2022Q3 us-gaap Lease Cost
LeaseCost
708000
us-gaap Lease Cost
LeaseCost
706000
us-gaap Lease Cost
LeaseCost
1650000
CY2023Q3 us-gaap Operating Lease Cost
OperatingLeaseCost
393000
CY2022Q3 us-gaap Operating Lease Cost
OperatingLeaseCost
788000
us-gaap Operating Lease Cost
OperatingLeaseCost
1014000
us-gaap Operating Lease Cost
OperatingLeaseCost
1737000
CY2023Q3 us-gaap Variable Lease Cost
VariableLeaseCost
138000
CY2022Q3 us-gaap Variable Lease Cost
VariableLeaseCost
160000
us-gaap Variable Lease Cost
VariableLeaseCost
319000
us-gaap Variable Lease Cost
VariableLeaseCost
334000
CY2023Q3 us-gaap Sublease Income
SubleaseIncome
300000
CY2022Q3 us-gaap Sublease Income
SubleaseIncome
240000
us-gaap Sublease Income
SubleaseIncome
627000
us-gaap Sublease Income
SubleaseIncome
421000
CY2023Q3 us-gaap Lease Cost
LeaseCost
231000
CY2022Q3 us-gaap Lease Cost
LeaseCost
708000
us-gaap Lease Cost
LeaseCost
706000
us-gaap Lease Cost
LeaseCost
1650000
CY2023Q3 us-gaap Operating Lease Payments
OperatingLeasePayments
983000
CY2022Q3 us-gaap Operating Lease Payments
OperatingLeasePayments
2225000
us-gaap Operating Lease Payments
OperatingLeasePayments
2127000
us-gaap Operating Lease Payments
OperatingLeasePayments
4533000
us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
585000
CY2023Q3 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P1Y10M24D
CY2023Q3 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.044
nxgn Retired Amount Capitalized Computer Software Amortization
RetiredAmountCapitalizedComputerSoftwareAmortization
9841000
CY2023Q1 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
44238000
CY2023Q1 us-gaap Deposits Assets Noncurrent
DepositsAssetsNoncurrent
7447000
CY2023Q3 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
1815000
CY2023Q3 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
3520000
CY2023Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
572000
CY2023Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
143000
CY2023Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
150000
CY2023Q3 nxgn Lessee Operating Lease Liability Payments Due After Year Four
LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFour
13000
CY2023Q3 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
6213000
CY2023Q3 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
278000
CY2023Q3 us-gaap Operating Lease Liability
OperatingLeaseLiability
5935000
us-gaap Number Of Operating Segments
NumberOfOperatingSegments
1
CY2023Q3 us-gaap Goodwill
Goodwill
322001000
CY2023Q1 us-gaap Goodwill
Goodwill
321756000
CY2023Q3 us-gaap Capitalized Computer Software Gross
CapitalizedComputerSoftwareGross
139371000
CY2023Q1 us-gaap Capitalized Computer Software Gross
CapitalizedComputerSoftwareGross
131791000
CY2023Q3 us-gaap Capitalized Computer Software Accumulated Amortization
CapitalizedComputerSoftwareAccumulatedAmortization
79496000
CY2023Q1 us-gaap Capitalized Computer Software Accumulated Amortization
CapitalizedComputerSoftwareAccumulatedAmortization
77275000
CY2023Q3 us-gaap Capitalized Computer Software Net
CapitalizedComputerSoftwareNet
59875000
CY2021Q1 us-gaap Ratio Of Indebtedness To Net Capital1
RatioOfIndebtednessToNetCapital1
3.75
CY2022Q2 us-gaap Ratio Of Indebtedness To Net Capital1
RatioOfIndebtednessToNetCapital1
4
CY2021Q1 nxgn Related Adjusted Covenant Period Option
RelatedAdjustedCovenantPeriodOption
4.25
CY2022Q2 nxgn Related Adjusted Covenant Period Option
RelatedAdjustedCovenantPeriodOption
4.75
CY2021Q1 nxgn Restricted Payments To Satisfy Leverage Conditions
RestrictedPaymentsToSatisfyLeverageConditions
11500000
CY2022Q2 nxgn Restricted Payments To Satisfy Leverage Conditions
RestrictedPaymentsToSatisfyLeverageConditions
25000000
CY2023Q3 us-gaap Line Of Credit
LineOfCredit
0
CY2023Q1 us-gaap Line Of Credit
LineOfCredit
0
CY2023Q3 us-gaap Line Of Credit Facility Remaining Borrowing Capacity
LineOfCreditFacilityRemainingBorrowingCapacity
300000000
CY2023Q1 us-gaap Line Of Credit Facility Remaining Borrowing Capacity
LineOfCreditFacilityRemainingBorrowingCapacity
300000000
CY2023Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
53867000
CY2023Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
98719000
CY2023Q3 us-gaap Restricted Cash And Cash Equivalents At Carrying Value
RestrictedCashAndCashEquivalentsAtCarryingValue
4914000
CY2023Q1 us-gaap Restricted Cash And Cash Equivalents At Carrying Value
RestrictedCashAndCashEquivalentsAtCarryingValue
7269000
CY2023Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
58781000
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
105988000
CY2023Q3 us-gaap Deferred Finance Costs Noncurrent Net
DeferredFinanceCostsNoncurrentNet
1244000
CY2023Q1 us-gaap Deferred Finance Costs Noncurrent Net
DeferredFinanceCostsNoncurrentNet
1498000
CY2023Q3 us-gaap Other Assets Miscellaneous Noncurrent
OtherAssetsMiscellaneousNoncurrent
9996000
CY2023Q1 us-gaap Other Assets Miscellaneous Noncurrent
OtherAssetsMiscellaneousNoncurrent
9189000
CY2023Q3 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
46217000
CY2023Q3 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
22673000
CY2023Q1 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
26365000
CY2023Q3 us-gaap Capitalized Contract Cost Net Current
CapitalizedContractCostNetCurrent
14363000
CY2023Q1 us-gaap Capitalized Contract Cost Net Current
CapitalizedContractCostNetCurrent
13813000
CY2023Q3 us-gaap Debt Securities Available For Sale Accrued Interest After Allowance For Credit Loss Current
DebtSecuritiesAvailableForSaleAccruedInterestAfterAllowanceForCreditLossCurrent
916000
CY2023Q1 us-gaap Debt Securities Available For Sale Accrued Interest After Allowance For Credit Loss Current
DebtSecuritiesAvailableForSaleAccruedInterestAfterAllowanceForCreditLossCurrent
699000
CY2023Q3 us-gaap Other Assets Current
OtherAssetsCurrent
1732000
CY2023Q1 us-gaap Other Assets Current
OtherAssetsCurrent
2039000
CY2023Q3 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
39684000
CY2023Q1 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
42916000
CY2023Q3 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
62521000
CY2023Q1 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
67021000
CY2023Q3 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
57582000
CY2023Q1 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
60600000
CY2023Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
4939000
CY2023Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
6421000
CY2023Q3 us-gaap Capitalized Contract Cost Net Noncurrent
CapitalizedContractCostNetNoncurrent
27499000
CY2023Q1 us-gaap Capitalized Contract Cost Net Noncurrent
CapitalizedContractCostNetNoncurrent
26104000
CY2023Q3 us-gaap Deposits Assets Noncurrent
DepositsAssetsNoncurrent
7478000
CY2023Q3 us-gaap Accrued Bonuses Current
AccruedBonusesCurrent
11670000
CY2023Q1 us-gaap Accrued Bonuses Current
AccruedBonusesCurrent
15550000
CY2023Q3 us-gaap Accrued Vacation Current
AccruedVacationCurrent
13244000
CY2023Q1 us-gaap Accrued Vacation Current
AccruedVacationCurrent
13271000
CY2023Q3 us-gaap Accrued Sales Commission Current
AccruedSalesCommissionCurrent
3148000
CY2023Q1 us-gaap Accrued Sales Commission Current
AccruedSalesCommissionCurrent
5166000
CY2023Q3 nxgn Accrued Payroll Taxes And Other Current
AccruedPayrollTaxesAndOtherCurrent
345000
CY2023Q1 nxgn Accrued Payroll Taxes And Other Current
AccruedPayrollTaxesAndOtherCurrent
2254000
CY2023Q3 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
28407000
CY2023Q1 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
36241000
CY2023Q3 nxgn Accrued Acquisition Costs Current
AccruedAcquisitionCostsCurrent
7861000
CY2023Q3 us-gaap Contract With Customer Refund Liability Current
ContractWithCustomerRefundLiabilityCurrent
7136000
CY2023Q1 us-gaap Contract With Customer Refund Liability Current
ContractWithCustomerRefundLiabilityCurrent
5417000
CY2023Q3 nxgn Sales Returns Reserves And Other Customer Liabilities Current
SalesReturnsReservesAndOtherCustomerLiabilitiesCurrent
5614000
CY2023Q1 nxgn Sales Returns Reserves And Other Customer Liabilities Current
SalesReturnsReservesAndOtherCustomerLiabilitiesCurrent
5390000
CY2023Q3 nxgn Care Services Liabilities Current
CareServicesLiabilitiesCurrent
4914000
CY2023Q1 nxgn Care Services Liabilities Current
CareServicesLiabilitiesCurrent
7269000
CY2023Q3 us-gaap Interest Payable Current
InterestPayableCurrent
4081000
CY2023Q1 us-gaap Interest Payable Current
InterestPayableCurrent
4244000
CY2023Q3 nxgn Accrued Hosting Costs Current
AccruedHostingCostsCurrent
3553000
CY2023Q1 nxgn Accrued Hosting Costs Current
AccruedHostingCostsCurrent
873000
CY2023Q3 nxgn Accrued Electronic Data Interchange Expense Current
AccruedElectronicDataInterchangeExpenseCurrent
3068000
CY2023Q1 nxgn Accrued Electronic Data Interchange Expense Current
AccruedElectronicDataInterchangeExpenseCurrent
3064000
CY2023Q3 nxgn Accrued Outsourcing Expenses Current
AccruedOutsourcingExpensesCurrent
2785000
CY2023Q1 nxgn Accrued Outsourcing Expenses Current
AccruedOutsourcingExpensesCurrent
3023000
CY2023Q3 us-gaap Accrued Employee Benefits Current
AccruedEmployeeBenefitsCurrent
2667000
CY2023Q1 us-gaap Accrued Employee Benefits Current
AccruedEmployeeBenefitsCurrent
3195000
CY2023Q3 us-gaap Self Insurance Reserve Current
SelfInsuranceReserveCurrent
2299000
CY2023Q1 us-gaap Self Insurance Reserve Current
SelfInsuranceReserveCurrent
2359000
CY2023Q3 nxgn Accrued Consulting And Outside Services
AccruedConsultingAndOutsideServices
2002000
CY2023Q1 nxgn Accrued Consulting And Outside Services
AccruedConsultingAndOutsideServices
3957000
CY2023Q3 us-gaap Accrued Royalties Current
AccruedRoyaltiesCurrent
1838000
CY2023Q1 us-gaap Accrued Royalties Current
AccruedRoyaltiesCurrent
3248000
CY2023Q3 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
907000
CY2023Q1 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
782000
CY2023Q3 us-gaap Sales And Excise Tax Payable Current
SalesAndExciseTaxPayableCurrent
309000
CY2023Q1 us-gaap Sales And Excise Tax Payable Current
SalesAndExciseTaxPayableCurrent
1746000
CY2023Q1 nxgn Accrued Legal Settlement
AccruedLegalSettlement
33990000
CY2023Q3 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
5963000
CY2023Q1 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
5242000
CY2023Q3 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
54997000
CY2023Q1 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
83799000
CY2023Q3 us-gaap Business Combination Contingent Consideration Liability Noncurrent
BusinessCombinationContingentConsiderationLiabilityNoncurrent
4200000
CY2023Q1 us-gaap Business Combination Contingent Consideration Liability Noncurrent
BusinessCombinationContingentConsiderationLiabilityNoncurrent
3800000
CY2023Q3 nxgn Uncertain Tax Position Net Of Research And Development Tax Credit
UncertainTaxPositionNetOfResearchAndDevelopmentTaxCredit
4195000
CY2023Q1 nxgn Uncertain Tax Position Net Of Research And Development Tax Credit
UncertainTaxPositionNetOfResearchAndDevelopmentTaxCredit
3950000
CY2023Q3 us-gaap Other Sundry Liabilities Noncurrent
OtherSundryLiabilitiesNoncurrent
642000
CY2023Q1 us-gaap Other Sundry Liabilities Noncurrent
OtherSundryLiabilitiesNoncurrent
524000
CY2023Q3 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
9037000
CY2023Q1 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
8274000
CY2023Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
1641000
CY2023Q3 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.245
CY2022Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
5707000
CY2022Q3 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.295
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
4031000
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.264
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
5460000
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.27
CY2023Q3 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
6198000
CY2023Q1 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
5911000
nxgn Period Within Which Company Does Not Anticipate Unrecognized Tax Benefit To Change
PeriodWithinWhichCompanyDoesNotAnticipateUnrecognizedTaxBenefitToChange
within the next twelve months
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
5055000
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
13623000
us-gaap Net Income Loss
NetIncomeLoss
11211000
us-gaap Net Income Loss
NetIncomeLoss
14771000
CY2023Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
67074000
CY2022Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
67806000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
66749000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
67698000
CY2023Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.08
CY2022Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.2
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.17
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.22
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
5055000
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
13623000
us-gaap Net Income Loss
NetIncomeLoss
11211000
us-gaap Net Income Loss
NetIncomeLoss
14771000
CY2023Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
67074000
CY2022Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
67806000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
66749000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
67698000
CY2023Q3 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
616000
CY2022Q3 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
616000
us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
531000
us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
655000
CY2023Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
67690000
CY2022Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
68422000
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
67280000
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
68353000
CY2023Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.07
CY2022Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.2
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.17
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.22
CY2023Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
9466000
CY2022Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
8687000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
17422000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
17453000
CY2023Q3 us-gaap Employee Service Share Based Compensation Tax Benefit From Compensation Expense
EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense
2250000
CY2022Q3 us-gaap Employee Service Share Based Compensation Tax Benefit From Compensation Expense
EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense
2078000
us-gaap Employee Service Share Based Compensation Tax Benefit From Compensation Expense
EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense
4144000
us-gaap Employee Service Share Based Compensation Tax Benefit From Compensation Expense
EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense
4123000
CY2023Q3 us-gaap Allocated Share Based Compensation Expense Net Of Tax
AllocatedShareBasedCompensationExpenseNetOfTax
7216000
CY2022Q3 us-gaap Allocated Share Based Compensation Expense Net Of Tax
AllocatedShareBasedCompensationExpenseNetOfTax
6609000
us-gaap Allocated Share Based Compensation Expense Net Of Tax
AllocatedShareBasedCompensationExpenseNetOfTax
13278000
us-gaap Allocated Share Based Compensation Expense Net Of Tax
AllocatedShareBasedCompensationExpenseNetOfTax
13330000
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
1130813
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
14.75
CY2023 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P1Y8M12D
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
3011000
us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
201824
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
14.33
nxgn Share Based Compensation Arrangement By Share Based Payment Award Options Exercised Weighted Average Remaining Contractual Term
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisedWeightedAverageRemainingContractualTerm
P1Y3M18D
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
254000
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
500
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
0
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod
4700
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice
16.64
CY2023Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
923789
CY2023Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
14.83
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P1Y6M
CY2023Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
8224000
CY2023Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber
923789
CY2023Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice
14.83
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1
P1Y6M
CY2023Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue
8224000
CY2023Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber
923789
CY2023Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice
14.83
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P1Y6M
CY2023Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Aggregate Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue
8224000
CY2021Q4 us-gaap Stock Repurchase Program Authorized Amount1
StockRepurchaseProgramAuthorizedAmount1
60000000
CY2022Q4 us-gaap Stock Repurchase Program Authorized Amount1
StockRepurchaseProgramAuthorizedAmount1
100000000
us-gaap Treasury Stock Shares Acquired
TreasuryStockSharesAcquired
0
nxgn Stock Repurchased Available During Period Value
StockRepurchasedAvailableDuringPeriodValue
74303000
nxgn Applicable Program Documentation Period
ApplicableProgramDocumentationPeriod
P365D
CY2023Q3 us-gaap Payments For Legal Settlements
PaymentsForLegalSettlements
31268000
CY2023Q3 us-gaap Legal Fees
LegalFees
1200000
CY2023Q2 nxgn Number Of Individuals Impacted In Security Incident
NumberOfIndividualsImpactedInSecurityIncident
1000000

Files In Submission

Name View Source Status
0000950170-23-054878-index-headers.html Edgar Link pending
0000950170-23-054878-index.html Edgar Link pending
0000950170-23-054878.txt Edgar Link pending
0000950170-23-054878-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
img76146113_0.jpg Edgar Link pending
MetaLinks.json Edgar Link pending
nxgn-20230930.htm Edgar Link pending
nxgn-20230930.xsd Edgar Link pending
nxgn-ex31_1.htm Edgar Link pending
nxgn-ex31_2.htm Edgar Link pending
nxgn-ex32_1.htm Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
nxgn-20230930_lab.xml Edgar Link unprocessable
nxgn-20230930_pre.xml Edgar Link unprocessable
nxgn-20230930_htm.xml Edgar Link completed
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R69.htm Edgar Link pending
R7.htm Edgar Link pending
R70.htm Edgar Link pending
R71.htm Edgar Link pending
R72.htm Edgar Link pending
R73.htm Edgar Link pending
R74.htm Edgar Link pending
R75.htm Edgar Link pending
R76.htm Edgar Link pending
R77.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
nxgn-20230930_def.xml Edgar Link unprocessable
nxgn-20230930_cal.xml Edgar Link unprocessable